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Abstract
Characterizing the stability of the gut microbiome is important to exploit it as a therapeutic target
and diagnostic biomarker. We metagenomically and metatranscriptomically sequenced the faecal
microbiomes of 308 participants in the Health Professionals Follow-Up Study. Participants
provided four stool samples—one pair collected 24–72 h apart and a second pair ~6 months later.
Within-person taxonomic and functional variation was consistently lower than between-person
variation over time. In contrast, metatranscriptomic profiles were comparably variable within and
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between subjects due to higher within-subject longitudinal variation. Metagenomic instability
accounted for ~74% of corresponding metatranscriptomic instability. The rest was probably
attributable to sources such as regulation. Among the pathways that were differentially regulated,
most were consistently over- or under-transcribed at each time point. Together, these results
suggest that a single measurement of the faecal microbiome can provide long-term information
regarding organismal composition and functional potential, but repeated or short-term measures
may be necessary for dynamic features identified by metatranscriptomics.

Author Manuscript

Understanding the temporal dynamics of the healthy adult gut microbiome is integral in
leveraging these microbial communities to promote human health. Large-scale changes in
microbial composition have been associated with host health overall1–3, but inferring
causality and developing personalized therapies will require large-scale prospective cohort
studies. Furthermore, to exploit the faecal microbiome as a predictive biomarker or
eventually as a diagnostic tool in clinical settings, it is critical to be able to discriminate
between normal versus pathological variation over time4.

Author Manuscript

Previous efforts have provided excellent characterization of the ecological stability of the
adult faecal microbiome4–13. All measures of stability in microbial communities must be in
the context of relative differences since, despite daily variability in species’ relative
abundances, microbial communities in the gut microbiome have been observed to be
generally consistent over time, even on the scale of years or decades4,5,14,15. This relative
stability appears to be due to individually persistent strains within individual hosts5,16.
Moreover, specific inter-individual differences in community structures appear to be
preserved over the long-term17, allowing an individual’s faecal microbiome to be uniquely
distinguished from that of others to serve as a faecal microbial fingerprint13. Nonetheless,
despite the relative stability of the community profile over the long-term, recent studies have
shown that host lifestyle or exposures such as a sudden change in diet, the initiation of
antibiotics or the acquisition of pathogenic species can lead to profound disruptions in the
microbiome9,18,19. When such pressures are lifted, the host’s faecal microbiome generally
recovers to a composition comparable to its original state9.

Author Manuscript

An understanding of microbiome stability as it affects taxonomic and functional features is
vital for applying it diagnostically or prognostically in long-term public health studies.
Different molecular features, including strain membership, species abundances, functional
profiles or metatranscription, may all prove to be informative regarding host health
conditions and they are likely to differ dramatically in their relative stability within and
between subjects over time20. The Human Microbiome Project (HMP), for example, found
that in the absence of perturbations from disease or overt xenobiotics, metagenomic
functional profiles were more comparable between individuals, while strains were stable
within subjects17. Even fewer studies have focused on the metatranscriptome, an indicator of
different aspects of microbial functional activity21,22. Finally, the dynamics of response in
any of these features to known dietary and xenobiotic perturbations are themselves not yet
fully known23,24. Thus, the magnitude of changes in microbial composition, functional
potential and gene expression that occur over various time intervals and their utility for
molecular epidemiology are unclear.
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To address these knowledge gaps, we deeply characterized the faecal microbiome among
308 individuals enroled in the Men’s Lifestyle Validation Study (MLVS), nested within the
ongoing population-based Health Professionals Follow-up Study (HPFS)—a prospective
cohort of 51,529 men followed since 1986. This cohort provided an unparalleled opportunity
to apply insights from community ecology and epidemiology to characterize the stability of
the faecal microbiome structure and function over time. Specifically, we hypothesized that
inter-individual differences in faecal microbiome communities and metagenomes would
persist over short- (24–72 h) and intermediate-term (6 months) intervals, but that
metatranscriptomes would demonstrate greater variability over time. The work described
here characterizing faecal microbial stability is accompanied by further research on
molecular function in the faecal metagenome and metatranscriptome population25. These
studies will provide a foundation for leveraging the faecal microbiome as a biomarker for
population-based cohort studies and provide insight into how metagenomics and
metatranscriptomics relate to each other over time.

Author Manuscript

Results
The faecal metagenome is more stable than the metatranscriptome

Author Manuscript

We first quantified the longitudinal stability of metagenomic taxonomic profiles, functional
profiles and metatranscriptomes in MLVS subjects. Our approach is detailed in Fig. 1.
Participants provided up to four stool samples—a set of stool samples collected 24–72 h
apart followed by collection of a second set approximately 6 months later. DNA was
extracted from 929 samples collected from all 308 men. RNA was extracted and reversetranscribed to complementary DNA from 378 samples from participants who provided a
stool at both sampling time points and who did not report the use of antibiotics within the
past year. All samples were then sequenced using the Illumina HiSeq platform (see
Methods). Raw sequence data were filtered to remove low-quality and human host reads and
features with low overall relative abundance. Metagenomic and metatranscriptomic reads
were profiled for functional and taxonomic composition using HUMAnN2 (ref. 26) and
MetaPhlAn2 (ref. 27), respectively.

Author Manuscript

We compared the within-person stability of the faecal metatranscriptome (functional
elements from RNA) with the stability of taxonomic composition (species from DNA) and
the metagenome (functional elements from DNA) over short (24–72 h) and intermediate (6
month) time intervals. This was assessed by calculating two β-diversity metrics—the Jaccard
index (for membership) and Bray–Curtis (BC) dissimilarity (for abundance)—between an
individual’s samples collected over the study period. In accordance with our earlier pilot
study21, the metagenomic functional potential (DNA) was more stable than the
metatranscriptome (RNA), which was in turn more stable than taxonomic profile abundances
(species) (Fig. 2a).
In addition, we tested whether the stability of microbiome features was consistent over
short- and intermediate-term intervals. Species, DNA and RNA features that remained stable
within a subject over a 24–72 h period tended to be similarly stable over 6 months
(Spearman’s r =0.99, two-tailed P <2.2×10−16), suggesting the presence of a subset of
features that can be consistently measured over time.
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Between-person exceeds within-person metagenomic variation
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As in previous studies of the faecal microbiome17, individuals’ microbial community
structure and metagenomic functional potential were more self-similar (red boxes) over time
than between subjects (blue boxes) (Fig. 2b). This remained consistent over short- (24–72 h)
and intermediate-term (6 month) periods (within-person variation versus between-person
variation for all four Mann–Whitney U tests: P <2.2×10−16). In contrast, we found that
within- and between-subject variation over short- and intermediate-term periods was
comparable for metatranscriptomes (short term Mann–Whitney U test: P = 0.25;
intermediate term Mann–Whitney U test: P =0.50).
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To additionally quantify the proportion of variation that can be attributed to between-subject
variation for the purposes of prospective population-based cohort studies, we estimated
intra-class correlation coefficients (ICCs). The majority of species and genes (86.8 and
92.8%, respectively) retained ICCs greater than 0.40 over the longest sampling interval in
our study. In contrast, only a small fraction of transcripts (0.79%) had an ICC greater than
0.40 (Supplementary Table 1).
Taken together, these data suggest that specific inter-individual differences in faecal
microbiome organismal composition and functional potential appear to be preserved over
intervals up to at least six months and thus may be more reliably associated with long-term
health outcomes using a limited number of measurements. In contrast, the more dynamic
features of the metatranscriptome may be more informative regarding short-term events.
Feature abundance and prevalence are associated with stability

Author Manuscript
Author Manuscript

Feature consistency over short- and intermediate-term periods led us to consider if there may
be properties inherent to features that contribute to stability across all hosts. Across a range
of body sites, overall taxonomic stability of the human microbiome is correlated with feature
abundance and prevalence13. We extended these results by exploring the correlations
between these two ecological properties and the stability of individual organisms in the
faecal microbiome, as well as the stability of the genomic and transcriptomic levels of
individual enzymes. As in previous analyses where dissimilarity metrics have been used for
individual features5, using the complement of within-person BC dissimilarity score (1 – BC)
over the longest interval in our study (time point 1 versus time point 4; ~6 months), we
similarly found that baseline feature prevalence and abundance were also strongly and
positively correlated with not only organismal composition, but also genomic and
transcriptional stability (Fig. 3). Many species that were highly abundant and prevalent in
this population were highly stable, including the well-characterized Bacteroides uniformis
(dark green circle) and Faecalibacterium prausnitzii (orange circle)28. In contrast, species
that were of low prevalence and abundance were less stable, including those that were
probably carried from the oral cavity including Lactococcus lactis (black circle) and
Streptococcus thermophilus (dark purple circle)21,29. Similarly, enzymes such as RNA
polymerase (red circle) (EC (Enzyme Commission) 2.7.7.6), which are essential for
prokaryotic function, were universally prevalent, highly abundant and stably expressed at the
genomic and transcriptional level.
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Notably, however, there were select features for which the stability levels did not correspond
with their prevalence or abundance. For example, Sutterella wadsworthensis (blue circle),
was in the bottom quintile for prevalence and the bottom half for abundance, but it was in
the top quintile for stability. This may be due to the role of this species’ lone production of
the adenosine 3′-phosphate-5′-phosphosulfate-independent sulfuryl transferase (EC
2.8.2.22)—an important microbial enzyme involved in the detoxification of phenolic
compounds30,31. Similarly, Bacteroides plebius (light purple circle), found to occupy a
unique role in starch utilization, was found in the bottom quintile for prevalence but in the
top quintile for stability32. Additionally, as observed in the HMP, there were genes that were
universally prevalent at the DNA level but of relatively low genomic abundance17. Many of
these enzymes had some of the most variable gene expression. For example, the pair of
enzymes thiaminase I and II (EC 2.5.1.2 and EC 3.5.99.2), which are involved in the
microbial degradation of thiamin, possessed DNA sequences detected in 100% of
participants, but were within the bottom 5% of stable transcripts33. Similarly, the enzyme
ErmC (EC 2.1.1.184), which encodes one of the macrolide resistance genes was universally
prevalent at the genomic level but was unstable at the RNA level and of intermediate
stability at the genomic level34.
Host factors that may influence faecal microbiome stability

Author Manuscript

In addition to examining determinants of stability for specific features, we assessed whether
there were lifestyle factors or behaviours at the time of stool collection that could explain
global instability of the faecal microbiome for each individual. There have been inconsistent
data on the effects of antibiotics and bowel preparation on the faecal microbiome
composition and limited data on temporal change in the metagenome19,24,35–38. In addition,
ecological theory suggests that species-rich communities may have a greater compensatory
capacity for disturbances in the ecosystem39,40.

Author Manuscript

In an exploratory analysis, we examined the association of putative host or environmental
factors that may influence the stability of microbial community structure or pathways over a
longer period. To do this, we calculated BC dissimilarity values for each individual over the
longest sampling interval (around six months) using species, genes and transcripts as our
response variables. As shown in Table 1, there were few factors that consistently explained
instability. However, common predictive factors across feature types included mean Shannon
index values (α-diversity) and exposure to a bowel laxative preparation within the two
months before collection. Antibiotic use during the six-month period between sample
collection seemed to affect genomic instability to a slightly greater extent than species
instability. However, the overall low correspondence between antibiotic usage and
dissimilarity suggests that faecal ecological variability may either be attributed to additional
exogenous factors not measured here or to endogenous and perhaps stochastic host–
microbial interactions.
Relating metagenomic and metatranscriptomic stability over time
Next, we considered the degree to which transcriptomic stability is related to metagenomic
stability, since the central dogma suggests that DNA copy number changes are likely to
influence transcript levels. Recent evidence from a pilot study involving a subset of these
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participants (n = 8) found that many gene and transcript relative abundances were well
correlated and that a substantial fraction (41%) of microbial transcripts were basally
regulated21. Again using the complement of the within-person BC dissimilarity score over
six months as our metric of stability, we found that genomic instability appears to explain a
large proportion of transcriptomic instability (Spearman’s r = 0.86; r2 = 0.74 = 74%; P
<2.2×10−16). To further investigate whether this trend is driven by a small number of highly
expressed genes, we divided our dataset into genes that were prevalently expressed (defined
as transcripts detected in >90% of samples; n = 1,049) and genes that were variably detected
(n =754). When comparing r2 values for these two groups, we did not observe an
appreciable difference (0.56 versus 0.48). However, we found that among only the
transcripts in the bottom 10% of prevalence (n = 176), a similar strength in association was
not seen (r2 =0.01), suggesting that measured expression of these genes is influenced by
other factors.

Author Manuscript

In addition, we investigated whether dominant expression of stable versus unstable genes
varied according to species. For each transcript, a dominant contributing species was
identified based on the maximal average contributing organism for each transcript from
HUMAnN2 (see Methods). We then ranked species according to the total number of genes
that they dominantly expressed (Fig. 4). As shown, Bacteroides species are dominant
contributors to the greatest number of genes expressed, as well as dominant contributors to
the expression of the most stable transcripts. In contrast, Streptococcus species are dominant
contributors to the expression of some of the most unstable transcripts. Interestingly, these
are not typically viable gut residents21, suggesting that some species play more variable
roles because they are rare, transitory, more prone to influence by environmental factors or
possibly under-sampled.

Author Manuscript

Stability of gene expression over time
The previous section highlighted that much of the transcriptional variability over time for
each feature was associated with changes in the metagenome. Thus, next we queried what
proportion of the remainder of transcriptional variation could be explained by differences in
the transcriptional expression of features over time. In an approach similar to that performed
in the pilot study21, we identified significantly differentially transcribed pathways, defined
as having a mean log RNA/DNA abundance ratio >2 for all four time points and then
explored where they overlapped. Of the 218 pathways that were significantly differentially
expressed, 79% were consistently over- or under-expressed across three or four time points
(Fig. 5a).

Author Manuscript

To better understand which pathways were most stably expressed, for each time point, we
computed the mean RNA/DNA ratio (see 'RNA/DNA normalization' in the Methods of the
accompanying manuscript by48 for each pathway across the 85 participants who gave 4
samples for transcriptomic analysis. We then calculated the coefficient of variation for these
means and ranked the pathways by their coefficient of variation (Fig. 5b). The top eight
resulting most stable pathways in terms of transcriptional regulation appear to be involved in
cellular housekeeping, such as carbon metabolism (stably over-expressed) and amino acid
synthesis (stably under-expressed).
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Discussion
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Here, we quantify faecal microbiome stability for prospective population-based cohort
studies, with a particular focus on the relationship between metatranscriptomic features and
the metagenome (both organismal composition and functional potential). See also ref. 48 for
a discussion of the molecular and functional activity. As expected from single organisms and
human studies, metatranscriptomic variation exceeded that of the metagenome. In addition,
unlike the metagenome, metatranscriptomic variation within individuals over time was
higher, to the point that it was comparable to variation between individuals. Taken in
combination with our accompanying report describing a relatively stable 'core'
metatranscriptome48, these findings, combined with previous reports21,23,24, suggest a
model in which gut microbial community function mirrors that of differentiated human cell
types: a subset of transcripts are prevalently active in the gut from varied microbes and
conditions, while the remainder respond dynamically to intrinsic or external factors, such as
diet.

Author Manuscript

In addition, we found the striking result that approximately 74% of the instability in the
faecal metatranscriptome can be explained by instability in the faecal metagenome. These
findings are similar to those from our pilot study, which showed that at a single time point,
more than half of the variation in microbial community gene expression can be explained by
metagenomic composition. This is best illustrated by our finding that some of the most
highly stable (as well as highly abundant and prevalent) species, such as B. uniformis, were
responsible for the dominant expression of a large number of stable genes. In contrast,
Streptococcus salivarius—an unstable species that is probably transiting from the oral
microbiome21—dominantly expresses many of the most variable genes. Similar findings
were found in relation to the regulation of gene expression. Of the genes we identified as
significantly differentially transcribed, nearly 80% were consistently over- or underexpressed. Many of these stably expressed pathways appeared to be essential for cellular
function or involved in glycolysis, the synthesis of amino acids or the production of shortchain fatty acids. Taken together, it appears that much of the metatranscriptomic variation in
stools over time might reflect changes in gene family copy number, driven by factors such as
the proliferation of microbes, introduction of new species or host-induced shifts in
community structures. In contrast, in the face of relative metagenomic stability, substantial
deviations from a common genomic profile may be associated with shifts in disease
state41,42.

Author Manuscript

Of course, we observed exceptions to these patterns, which may additionally explain some
of the instability in the function of the faecal microbiome. Some species, such as S.
wadsworthensis and Methanobrevibacter smithii, despite their stable presence, appear to be
dominant contributors to the expression of unstable genes. Especially in the case of
functionally unique taxa such as the archaea, this suggests specialized roles associated with
targeted, highly variable activity over time. In addition, we found gene families with levels
of RNA stability that were discordant with DNA stability, as well as several pathways that
were differentially transcribed (up or down) only at a single time point. Given the large
relative time scales of even our shortest gap (1–3 days) compared with transcriptional
regulation (minutes), these changes are difficult to interpret without further data, but they
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may indicate pathways particularly susceptible to modulation by xenobiotics, diet or other
targeted perturbations23,24. These outlying genes with high metagenomic stability but
variable metatranscriptomic levels, or the stable microbes leading to the expression of
unstable genes, are likely to play a critical role in our understanding of the impact of host
behaviour on the faecal microbiome48.

Author Manuscript

Finally, for the purposes of prospective, longitudinally followed cohort studies, our study is
consistent with previous work and indicates that many long-term features of the faecal
microbiome are well-represented in a single self-collected stool sample4,5,17,21. These
include strain composition, general taxonomic abundances and core metagenomic functional
profiles. Furthermore, our results suggest that, as expected, metatranscriptomes vary over
time and are appropriate markers for short-term exposures, and not necessarily long-term
exposure–disease relationships. They do, however, remain somewhat personalized, and
subsets of microbial transcripts are individually more stable. It remains to be determined
which of these microbiome features, if any, represent the best biomarkers for diagnosis or
prognosis of health conditions in diverse human populations.

Author Manuscript

Moving forward, the large-scale, population-based collection of stools is critical to exploring
the factors that promote a stable core functional microbiome, yet yield unique species and
metagenomic profiles. Prospective cohort studies characterizing the microbiome in relation
to lifestyle data, such as dietary and medication information, have already begun to explore
inter-individual variation and will be essential in mechanistically understanding the
interactions between the faecal microbiome and the host in the context of health and
disease17,43–45. Continuing to improve our understanding of the stability of the faecal
microbiome function is critical not only in determining the ecological dynamics of the
human microbiome25, but also for the promotion of human health.

Methods
Study population

Author Manuscript

The HPFS is an ongoing prospective cohort study that began in 1986 among 51,529 US
male podiatrists, dentists, osteopathic physicians, veterinarians, pharmacists and
optometrists aged 40 to 75 years at enrolment. In this study, participants returned
questionnaires every 2–4 years with greater than 90% follow-up to provide information
about lifestyle and dietary factors, medication use, and diagnoses of colorectal cancer and
other diseases. The MLVS was established among 700 men aged 52–81 years (median 69
years) nested within HPFS who had completed the 2010 food frequency questionnaire and
previously provided a blood sample. Men with coronary artery disease, stroke or transient
ischaemic attack, cancer (except squamous or basal cell skin cancer) or major neurological
disease (amyotrophic lateral sclerosis, Alzheimer’s, Parkinson’s, epilepsy or multiple
sclerosis) were excluded. The 308 individuals sampled in this study were recruited into the
MLVS starting in July 2012 and ending in July 2013. Participant recruitment and protocols
were approved by the Harvard T. H. Chan School of Public Health Institutional Review
Board #HSPH 22067-102. All participants provided informed consent for the study.
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Sample size rationale
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A tiered study design with metagenomic sequencing and a smaller batch of
metatranscriptomic sequencing was used to determine both the composition and metabolic
potential of the faecal microbiota. From the HMP findings of ~300 taxa per sample, our
sample was estimated to yield relative abundances with standard deviation quartiles of
(0.016, 0.027, 0.058) among rare taxa (present in < 50% of samples) and (0.081, 0.10, 0.15)
among common taxa (arcsine square root-transformed relative abundance units).
Sample collection

Author Manuscript

Participants provided up to four stool samples—a set of samples from two consecutive
bowel movements 24–72 h apart followed by collection of a second set of two such samples
approximately 6 months later. Our collection protocol had previously been validated (see
Supplementary Discussion)21. Briefly, participants deposited each bowel movement into a
plastic commode collection bowl and then, using a specially designed spoon attached to a
collection tube cap, faeces were scooped into a tube containing RNAlater. At each stool
collection, participants documented the date and time of defecation as well as the Bristol
score46. In addition, concurrent with each set of samples, participants completed a brief
questionnaire collecting information regarding their recent use of antibiotics, gastric-acidreducing medications, laxatives and probiotics, as well as other relevant exposures. At each
time point, participants stored the specimen in the RNAlater fixative at ambient temperature
until the specimen collected from the second bowel movement was produced. Each set of
stool specimens was then placed in a special mailing kit and returned at ambient temperature
by overnight mail. Upon receipt, the collection tubes were immediately placed into −80 °C
freezers.

Author Manuscript

Sample handling and nucleic acid extraction

Author Manuscript

DNA and RNA extraction, processing and sequencing were as published21. Briefly, 100 mg
stool aliquots were centrifuged at maximum speed to remove the excess of RNAlater. To the
pellet, 110 μl of Tris-EDTA buffer with Proteinase K (Qiagen) and lysozyme (Sigma–
Aldrich) (15 mg ml−1) were added with incubation on a laboratory shaker for 10 min. The
mechanical lysis was performed by the addition of a 1.2 ml RLT buffer with 2mercaptoethanol (Qiagen) and 1 ml of 0.1 mm glass beads (BioSpec Products), followed by
bead beating for 3 min. The debris were removed by centrifugation and the supernatant was
used in Qiagen AllPrep spin columns according to the manufacturer’s protocol (Qiagen).
The only exception was in the preparation of the RNA: 60 μl DNase solution was added to
buffer RW1 and incubated at room temperature for 15 min, followed by another wash with
RW1 buffer. A NanoDrop 1000 (Thermo Fisher Scientific) was used to determine the DNA
and RNA concentrations, quality and purity. SUPErase In was added to the aliquot before
freezing. RNA was extracted and reverse-transcribed to complementary DNA only from
stool samples spanning 6 months from participants who did not report the use of antibiotics
within the past year (Fig. 1). RNA sequencing (RNA-Seq) libraries were depleted for
ribosomal RNA using Ribo-Zero (Epicentre) as previously described21.
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DNA was extracted from all 929 samples. RNA was extracted from 378 samples derived
from a subset of 96 individuals who provided all four stool samples spanning the 6-month
study interval and who did not report the use of antibiotics within the past year.
Library prep, sequencing and taxonomic/functional profiling
We used the Nextera XT DNA Library Preparation Kit for whole-genome sequencing. For
RNA-Seq, we used RNAtag-Seq—a method to create an RNA-Seq library containing large
numbers of RNA samples that are bar-coded and pooled before library construction47. This
approach does not require poly(A) capture/enrichment or random priming.

Author Manuscript

Using Illumina HiSeq paired-end (2 × 101 nucleotides) shotgun sequencing, 929
metagenomes and 378 metatranscriptomes were obtained. Six RNA samples were not
sequenced due to platform constraints. After sequencing and before biocomputing quality
control, the sequencing depth (mean ±s.d.) for DNA was 3.8 ± 1.6 giganucleotides (Gnt).
After quality control, it was 1.8 ± 0.7 Gnt. For RNA, the mean sequencing depth was 2.8
± 2.4 Gnt before quality control and 1.2 ± 1.0 Gnt after. The quality control step included
the removal of human sequences, quality trimming and depletion of duplicate reads using
HMP protocols (HMP) with KneadData (http://huttenhower.sph.harvard.edu/kneaddata).
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We then performed taxonomic profiling with MetaPhlAn2 (ref. 27) and functional profiling
of genes and transcripts using HUMAnN2 (ref. 26). Outlier identification was performed and
eight samples were removed because their ordination scores in either dimension (NMDS1 or
NMDS2) were outside the range of the median ± 3 interquartile ranges. Notably, four of
these samples were provided by a participant who reported a history of colectomy
(Supplementary Fig. 1). Six RNA samples were removed because they did not have
matching DNA-sequenced samples. We subsequently filtered all taxonomic features with a
relative abundance less than 10−4 (0.01%) in greater than 10% of all samples. Similarly, for
DNA and RNA, we filtered all gene families with a relative abundance less than 10−5
(0.001%) in greater than 10% of all samples.
Statistical analysis

Author Manuscript

Variability in the relative abundance values for community composition, metagenomes and
metatranscriptomes within and between samples was determined by calculating the BC
dissimilarity metric for each individual over time17. Short-term intervals, as previously
described, were defined as consecutive bowel movements (24–72 h apart), whereas the
intermediate interval was six months—the longest sampling interval in the study. Similarly,
the Jaccard index was calculated within samples across time, where comparisons were
drawn between the first sample and the remaining three5. With these metrics, higher values
signify more variable features, whereas lower values indicate more stable features.
To estimate the reliability or reproducibility in measuring relative abundance values of
features over time, we calculated ICCs. Relative abundance values were first arcsine square
root-transformed to variance-stabilize data and better approximate normality and then, using
linear mixed-effects models with restricted maximum likelihood estimation, we divided the
between-person variance by the sum of the within- and between-person variances48. In a
previous study, in simulations on proportion data, this approach performed similarly to
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generalized linear mixed model-based estimates of ICCs using multiplicative models fitted
by penalized quasi-likelihood estimation and from additive models fitted by Markov chain
Monte Carlo sampling48.
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We explored whether several putative factors (bowel preparation use, antibiotic use, acidlowering medication, and so on) were associated with within-person community,
metagenome and metatranscriptome stability across the longest interval in our study using
linear models. The Shannon index was calculated to be the mean of the within-sample
diversity at time point 1 and time point 4. Acid-lowering medication use was determined by
the use of proton-pump inhibitors or H2 receptor antagonists more than once a week for two
months. Bowel preparation was determined as any use of bowel preparation in the two
months before stool collection. Antibiotic use was defined as the oral or intravenous
administration of antibiotics in the 12 months before stool collection. Those who never used
antibiotics were set as the reference level. 'Any antibiotics' users were defined as participants
using antibiotics at any point during the 12 months before the second stool collection and
'new antibiotics' users were defined as non-users of antibiotics before collection time point 1
who had initiated the use of antibiotics after the first collection and before the second. The
Bristol category change was determined by categorization of participant-reported Bristol
stool scores into hard (1–2), normal (3–4) and soft or liquid (5–7) categories and then
calculating the difference between the categories over time46.
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We examined associations between the baseline mean relative abundance and prevalence of
each feature versus feature stability, and how metagenomic variability correlated with
metatranscriptomic variability for each feature over time. As part of this, we investigated
whether dominant expression of stable genes versus the expression of unstable genes varied
according to species. For each transcript, a dominant contributing species was identified
based on the maximal average contribution to each transcript. We then ranked the species
according to the total number of genes that they dominantly expressed and (for presentation
purposes) selected those contributing to 30 or more and overlaid them on a scatterplot in
colour (grouped by genus). Examples of this process are presented in Figs. 3 and 4.
To test the stability of gene expression over time, we identified 740 pathways found in the
340 samples for which we had DNA and RNA data across all four time points. In total, 218
differentially transcribed pathways were defined as having a mean log10(RNA/DNA)
significantly different from zero at each later time point using a linear model. We subjected
these nominal P values to false discovery rate correction following the Benjamini–Hochberg
method with α = 0.05. We then explored the consistency of the differential regulation of
each pathway by exploring the overlap at each time point.
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Life Sciences Reporting Summary
Further information on experimental design is available in the Life Sciences Reporting
Summary.
Data availability
Sequence data have been deposited in the Sequence Read Archive under BioProject ID:
PRJNA354235. Data from the Health Professionals Follow-up Study, including metadata not
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included in the current manuscript but collected as a part of the MLVS, can be obtained
through written application. As per standard controlled access procedure, applications to use
HPFS resources will be reviewed by our External Collaborators Committee for scientific
aims, evaluation of the fit of the data for the proposed methodology and verification that the
proposed use meets the guidelines of the Ethics and Governance Framework and the consent
that was provided by the participants. Investigators wishing to use HFPS or MLVS cohort
data are asked to submit a brief (two pages) description of the proposed project ('letter of
intent') to E.B.R. (HPFS Director; erimm@hsph.harvard.edu).

Supplementary Material
Refer to Web version on PubMed Central for supplementary material.
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Fig. 1. Experimental design
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308 participants from the MLVS, nested within the HPFS cohort, were recruited to assess
the stability of microbiome communities, metagenomes and metatranscriptomes.
Participants provided up to four stool samples using a previously validated self-sampling
method21. One set of stool samples was collected 24–72 h apart followed by a second set
approximately 6 months later. Metagenomic and metatranscriptomic reads were generated to
provide taxonomic, functional metagenomic and transcriptional features for stability
assessment.
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Fig. 2. Inter-individual differences in organismal composition and functional potential appear to
be preserved, unlike the more variable metatranscriptomes

a, 1 – Jaccard Index (fraction of shared features) between all possible pairwise combinations
of the first faecal sample with the other three samples collected from each individual (n =
308). 95% confidence intervals are shown in grey. b, Bray–Curtis β-diversity scores within
and between subjects for short- (24–72 h; n = 308 individuals) and intermediate-term
intervals (6 months; n = 160 individuals). Here, species represents taxonomic profile
abundances, DNA represents metagenomic functional profiles, and RNA represents
metatranscriptomes. Boxplot whiskers include observations within 1.5 interquartile range of
the upper and lower quartiles.
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Fig. 3. Stability of individual species, genes and transcripts over 6 months is correlated with
average baseline relative abundance and prevalence

Each point represents an individual feature—species (n = 139), genes (n = 1,952) or
transcripts (n = 1,803). Coloured circles highlight species and gene families discussed in the
main text, according to the figure legend.
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Fig. 4. Relating metagenomic and metatranscriptomic stability over time
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Genomic instability appears to explain a large proportion of transcriptomic instability over
intermediate-term (6 month) periods (r2= 0.74); the metatranscriptome should typically be
no more stable than the metagenome. In addition, we investigated whether dominant
expression of stable genes versus expression of unstable genes varied according to species.
For each transcript (n = 1,803), a dominant contributing species was identified based on the
maximal average contribution to each transcript. We then ranked the species according to the
total number of genes that they dominantly expressed and (for presentation purposes)
selected those contributing to 30 or more and overlaid them on the scatterplot in colour
(grouped by genus). Each point represents an individual feature.
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Fig. 5. Exploring the stability of gene expression
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a, For a large proportion of transcriptional pathways over- or under-expressed over time in
the stool, this differential expression may be consistent. The Venn diagram shows
consistency of differentially transcribed pathways (mean RNA/DNA ratios >2 across at least
one time point; n = 218) across 4 stool samples. b, A subset (n = 8) of stably transcribed
pathways is highlighted, according to those with the lowest coefficient of variance of mean
RNA/DNA expression ratios across the four time points. Many of the stable pathways
appear to be involved in cellular housekeeping, such as carbon metabolism (over-expressed;
above dashed red line; >1) and amino acid synthesis (under-expressed; below dashed red
line; <1). Error bars indicate 95% confidence intervals.
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Bristol scores were assigned to three categories: 1–2 = hard; 3–4 = normal; 5–7 = soft or liquid.
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The reference level was no antibiotic use. 'Any antibiotic use' was defined as any use in the past 12 months before the second stool collection. 'New antibiotic use' was defined as new use of antibiotics
before the second collection. We did not assess transcriptomics in individuals who reported antibiotic use.
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Use of proton-pump inhibitors or H2 receptor antagonists more than once per week in the past two months.

All models were adjusted for median read depth (pass-filter reads).
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In an exploratory analysis, linear models were used to determine which of the measured factors predicted individuals’ dissimilarity in faecal microbiome communities and faecal microbiome pathways
between the first and last sample. All models were adjusted by the mean total number of reads that passed filtration per identification. n refers to the number of participants in each analysis. Statistically
significant values appear in bold.
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Supplementary discussion
Stool samples for this study were collected following a previously-established protocol
involving delivery of sample material fixed in RNAlater to the laboratory. 1 Analyses from
our pilot study demonstrated that two-day simulated shipping of RNAlater-fixed stool
aliquots had only a minimal perturbative effect on the gut metagenome and
metatranscriptome when compared to fresh-frozen sample collection protocols.1 Since
publication of our pilot work, other studies have confirmed no significant effect of
RNAlater on community composition.2,3 One study, however, has suggested differences
in evenness in microbial taxonomic composition in stool stored in RNAlater compared to
−80 °C controls.4 Notably, variation attributable to storage method was markedly smaller
than the variation explained by different sample time points. Furthermore, variation
attributed to RNAlater relative to freezing at -80℃, was comparable to that introduced by
sample storage in OMNIGene.Gut, another popular sample stabilization kit. Taken
together, the effect of RNAlater on microbiome sample composition is local, of very
small effect when significant at all, and no greater than that of any other currently used
sample stabilization method.

2

Supplementary Figure 1: Ordination plot of taxonomic profiles (n=929). 8 outliers (samples) were
removed. 4 of these came from one person who reported a colectomy at the time of participation in the
study.

3

Supplementary Table 1. Reliability in measuring relative abundance levels over short-term (24-72 hours)
and long-term (~6 months) intervals for the majority of species and gene families. Genes were most
highly repeatable, followed by species, and then distantly followed by RNA pathways. An ICC of <0.40
suggests poor repeatability, 0.40 to 0.75 indicates fair to good repeatability, and > 0.75 indicates excellent
49
repeatability .

Species (n=146)
DNA (n=1951)
RNA (n=3566)

Percent of features with an ICC > 0.40
Short-term
Long-Term
96.8%
86.8%
99.9%
92.8%
1.3%
0.79%
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